1 / 11Varun Beverages | Leading bottler of beverage major PepsiCo announced an investment of ₹413 crore by subscribing to 1,984,695 ordinary shares in its South African subsidiary, The Beverage Company Proprietary Ltd (Bevco), at a price of ZAR 453.47 per share. This acquisition results in an incremental shareholding of 2.42% in Bevco. The investment aims to assist Bevco in repaying its existing debt and strengthening its balance sheet for future business growth.
2 / 11NHPC | India’s largest hydropower company announced the receipt of the second on-account gross payment of ₹250 crore under its Mega Insurance Policy. This payment is related to the business interruption (BI) loss caused by the flash flood at the Teesta-V Power Station (510 MW) on October 4, 2023. Last year in August, a landslide at the Teesta-V Power Station (510 MW) affected parts of the Tail Race Tunnel (TRT), and a severe flash flood in the Teesta Basin in October 2023 led to a complete shutdown of the Teesta-5 power station.
3 / 11Hindustan Zinc | Vedanta Group company reported a 2% year-on-year decline in mined metal production for the third quarter of the current fiscal, totalling 265 kilotonnes (kt). The decrease was primarily due to lower ore production at the Agucha and SK mines, though this was partly offset by improved mined metal grades and mill recovery. However, the company’s mined metal output rose 3% compared to the previous quarter, driven by higher grades and increased production at Agucha and Zawar mines.
4 / 11Wockhardt | Pharmaceuticals firm announced that the Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for Community-Acquired Bacterial Pneumonia (CABP) in adults. Miqnaf is an ultra-short course, once-a-day, three-day treatment for CABP, including infections caused by multi-drug resistant (MDR) pathogens. The approval follows a positive recommendation from the Subject Expert Committee (SEC) of CDSCO to manufacture and market nafithromycin.
5 / 11Biocon | Biotechnology firm announced that its wholly owned subsidiary, Biocon Pharma Ltd, has received approval from the National Medical Products Administration (NMPA) in China for its Tacrolimus capsules in 0.5mg, 1mg, and 5mg strengths. Tacrolimus, an immunosuppressant, is used to prevent organ rejection in transplant patients by reducing the body’s immune response. This approval enhances Biocon’s portfolio of complex drug products and further strengthens its presence in the global pharmaceutical market.
6 / 11Avenue Supermarts | The company reported a strong performance for the third quarter of FY25, with standalone revenue from operations reaching ₹15,565.23 crore, marking a 17.5% increase compared to ₹13,247.33 crore in the same quarter last year. As of December 31, 2024, Avenue Supermarts operated 387 stores, Avenue Supermarts said in a regulatory filing.
7 / 11RITES | The company has bagged a significant contract from the Steel Authority of India Limited (SAIL), as per an exchange filing dated Thursday, January 2, 2024. The Bhilai Steel Plant, owned by SAIL, has awarded RITES the task of repairing 43 units of WDS6 locomotives under the “R3Y/R6Y Repair of WDS6 Locomotives” project. The contract, valued at ₹69.78 crore (excluding GST), will span three years and involve extensive repairs and maintenance of these integral locomotives.
8 / 11Bank of Maharashtra | The bank reported its third-quarter business update for FY25, with total business rising 16.9% year-on-year to ₹5.08 lakh crore, up from ₹4.34 lakh crore in the previous year. Gross advances rose by 21.2% to ₹2.29 lakh crore, driven by robust credit demand. Total deposits climbed 13.5% year-on-year to ₹2.79 lakh crore from ₹2.46 lakh crore. The CASA ratio, which reflects the share of low-cost current and savings account deposits, stood at 48.28%, down from 50.19% in the same quarter last year and 49.29% in the preceding quarter.
9 / 11Pricol | Automotive components maker said its board of directors has approved the divestment of its wiping business division to Auto Ignition Ltd for ₹ 20 crore on a slump sale basis. The business transfer agreement was executed on January 2, 2025, and the transaction is expected to be completed by January 31, 2025, subject to the satisfaction of conditions under the agreement.
10 / 11Honasa Consumer | The company announced that Master Zairus, the company’s Chief Business Officer, has tendered his resignation, effective from the closure of business hours on February 28, 2025. Zairus, who has been designated as Senior Management Personnel (SMP), will be stepping down from his role due to personal reasons.
11 / 11Capital Small Finance Bank | The bank reported a 12% year-on-year (YoY) increase in total deposits for the quarter ending December 31, 2024, reaching ₹8,384 crore. This growth was accompanied by notable advancements in loan disbursements, improved asset quality, and strong liquidity metrics. The bank’s gross advances reached ₹6,816 crore, marking a 19.2% year-on-year (YoY) increase. Nearly 99.8% of the portfolio remains secured.
